Improving Outcomes in EGFR-Mutated Non-Small-Cell Lung Cancer: Global Insights on Evolving Practice Standards
In this podcast episode, listen to thoracic oncologists Enriqueta Felip, MD, PhD, and Matthew Gubens, MD, MS, discuss evolving practice standards for EGFR-mutated NSCLC in the EU and US along with opportunities for improving outcomes.
Decera Clinical Education Oncology Podcast · Matthew Gubens MD MS, Enriqueta Felip MD PhD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Enriqueta Felip, MD, PhD, and Matthew Gubens, MD, MS, discuss evolving practice standards for EGFR-mutated non-small-cell lung cancer with topics including:
- Biomarker testing and strategies
- Optimal first-line therapy in patients with NSCLC
- Management of patients with CNS disease
- Selecting therapy for patients with noncanonical mutations
- Management strategies after progression on first-line EGFR TKI therapy
- Selecting therapy for patients with early stage disease
Presenters:
Enriqueta Felip, MD, PhD
Head, Thoracic Oncology Unit
Oncology Service
Vall d'Hebron University Hospital
Barcelona, Spain
Matthew Gubens, MD, MS
Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California
Content based on an online CME program supported by an educational grant from AstraZeneca.
Link to full program, including associated downloadable slidesets:
https://bit.ly/2PpFFHM
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.